Study Summary
This trial will investigate if mindfulness-based stress reduction can help improve quality of life, cognition, and mood in people with Parkinson's disease.
- Parkinson's Disease
- Quality of Life
- Mindfulness-Based Stress Reduction
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 0 Secondary · Reporting Duration: 0-9 weeks and 0-62 weeks
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Mindfulness Based Stress Reduction
1 of 2
Creative Education Care
1 of 2
Active Control
Non-Treatment Group
88 Total Participants · 2 Treatment Groups
Primary Treatment: Mindfulness Based Stress Reduction · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the upper limit of participants involved in this experiment?
"Affirmative. Clinicaltrials.gov indicates that this experiment, first posted on January 1st 2020, is actively enrolling individuals. 88 patients are required at a single medical centre." - Anonymous Online Contributor
Are there any vacancies available for individuals to join this medical investigation?
"Affirmative. Details available on clinicaltrials.gov demonstrate that the research is actively recruiting participants, with a launch date of 1/1/2020 and an update as recently as 3/21/2022. A total of 88 patients are being sought out from one unique location." - Anonymous Online Contributor